Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases

Volume: 47, Issue: 1, Pages: 26 - 52
Published: Jan 1, 2021
Abstract
This review summarizes the experience in laboratory- and industrial-scale syntheses of glycoconjugate vaccines used for prevention of infectious diseases caused by Haemophilus influenzae type b bacteria based on the linear capsular polysaccharide poly-3-β-D-ribosyl-(1→1)-D-ribitol-5-phosphate (PRP) or related synthetic oligosaccharide ligands. The methods for preparation of related oligosaccharide derivatives and results of the studies...
Paper Details
Title
Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases
Published Date
Jan 1, 2021
Volume
47
Issue
1
Pages
26 - 52
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.